Valerie Waters, Michelle Shaw, Lucy Perrem, Bradley S Quon, Elizabeth Tullis, Melinda Solomon, Jonathan H Rayment, Annick Lavoie, Sze Man Tse, Patrick Daigneault, Lara Bilodeau, April Price, Michael Nicholson, Melanie Chin, Michael Parkins, Martha L McKinney, Julian S Tam, Sanja Stanojevic, Hartmut Grasemann, Felix Ratjen
BACKGROUND: Elevated markers of systemic and pulmonary inflammation are associated with failure to recover lung function following pulmonary exacerbations (PExs) in people with cystic fibrosis (pwCF). Our aim was to determine whether adjuvant oral prednisone treatment would improve recovery of forced expiratory volume in 1 second (ppFEV1 ) in CF PExs not responding to antibiotic therapy. METHODS: This was a randomized, double-blind, placebo-controlled trial in pwCF treated with intravenous (IV) antibiotics for a PEx...
May 2, 2024: European Respiratory Journal